Published in Oncology and Therapy (2024)
Collaborator: Novartis
Authors: Pauline Frank, Julie Laurent, Lorraine Dallas, Pasquale Varriale, Andrew Ciupek
In our global survey, we sought to expand this understanding to people living with LC in countries across different regions, and to bring a more comprehensive understanding of the care pathway experiences in terms of disease management and impact on their daily lives, treatment decisionmaking, stakeholder involvement, and gaps in information/support services. In light of COVID-19 and the mobilization of patients to engage more online, we also sought to leverage online patient communities as participants for our survey. This enabled access to additional “real-world” patient populations beyond traditional channels such as local recruitment agencies and patient organizations.
